Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ACTRN12626001079336) titled 'Evaluating the efficiency of dosimetry following radioisotope therapy in patients with metastatic cancer' on Sept. 1.
Study Type: Interventional
Study Design:
Purpose: Diagnosis
Allocation: Non-randomised trial
Masking: Open (masking not used)
Assignment: Single group
Type of endpoint: Pharmacokinetics / pharmacodynamics
Primary Sponsor: Fiona Stanley Hospital
Condition:
Castrate resistant metastatic prostate cancer
prostate cancer
Castrate resistant metastatic prostate cancer
prostate cancer
Cancer - Prostate
Public Health - Health service research
Intervention:
We propose to introduce routine clinic...